Advances in Psychiatric Treatment (2008) 14: 208-216. doi: 10.1192/apt.bp.107.003483
© 2008 The Royal College of Psychiatrists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Related articles in APT
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Campion, J.
Right arrow Articles by Nurse, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Campion, J.
Right arrow Articles by Nurse, J.

Review of smoking cessation treatments for people with mental illness{dagger}

Jonathan Campion, Ken Checinski and Jo Nurse

Jonathan Campion is a specialist psychiatry registrar on the St George’s Psychiatry Training Scheme in London (Springfield Hospital, 61 Glenburnie Road, London SW17 7DJ, UK. Email: jonathan_campion{at}yahoo.co.uk). Areas of interest and research include public mental health, addiction, transcultural psychiatry and mental health service provision in low income countries. Ken Checinski is a senior lecturer in addictive behaviour at St George’s, University of London, and consultant psychiatrist with the Respond NHS substance misuse service in Surrey. Research and clinical interests include smoking and mental health, dual diagnosis, post-traumatic stress and public health education. Jo Nurse is national lead for public mental health and well-being at the Department of Health, England. She works as a consultant in public health in a regional public health group. Areas of interest and experience include health promotion, sexual health, healthy prison settings, mental well-being, substance misuse, violence and abuse.

This article reviews the current literature regarding treatments for smoking cessation in both the general population and in those with mental health problems. The gold-standard treatment for the general population is pharmacotherapy (nicotine replacement therapy, bupropion or varenicline) coupled with individual or group psychological support. This is also effective in helping people with mental illness to reduce or quit smoking, but care must be taken to avoid adverse medication interactions and to monitor antipsychotic medication in particular as cigarette consumption reduces.


Related articles in APT:

How to implement a smoke-free policy
Irene Cormac and Lisa McNally
APT 2008 14: 198-207. [Abstract] [Full Text]  

Smoking by people with mental illness and benefits of smoke-free mental health services
Jonathan Campion, Ken Checinski, Jo Nurse, and Ann McNeill
APT 2008 14: 217-228. [Abstract] [Full Text]  



This article has been cited by other articles:


Home page
 Adv. Psychiatr. Treat.Home page
J. Campion, K. Checinski, J. Nurse, and A. McNeill
Smoking by people with mental illness and benefits of smoke-free mental health services
Advan. Psychiatr. Treat., May 1, 2008; 14(3): 217 - 228.
[Abstract] [Full Text] [PDF]